Las Vegas, Nevada, United States
I’m a surgeon, scientist, and entrepreneur who has spent my career building at the intersection of clinical medicine, biotechnology, and innovation. Today, I serve as Co-Founder & CEO of Sundrata Clinic, a luxury wellness and aesthetics clinic in Las Vegas focused on delivering transformative results in weight loss, longevity medicine, and non-invasive aesthetics. At Sundrata, I lead our clinical consultation strategy, business development, operations, and patient experience—ensuring that every element of the clinic reflects our commitment to precision, personalization, and elevated care. I’m also the Founder & CEO of AzAverze, an AI-powered platform built to help service-based entrepreneurs scale their business with automation, integrated tools, and data-driven systems. AzAverze brings together CRM, project management, marketing, financial tracking, webinars, and coaching—everything an entrepreneur needs to run smarter and grow faster. Before founding these ventures, I trained in Cardiothoracic Surgery, earned a PhD in Biological Sciences (Immunology), and led global clinical development programs in biotech across liver disease, immunology, cardiovascular medicine, and rare diseases. I’ve served as a Chief Medical Officer and senior clinical leader, guiding novel therapies from translational discovery through to late-stage development. I also hold an MBA from MIT, which sharpened my ability to bridge science, business, and strategy at scale. What drives me is a deep belief in the power of precision science, intelligent systems, and human-centered innovation. Whether I’m building in medicine or in business, my goal is to create solutions that transform outcomes, elevate experience, and expand what’s possible. Let’s redefine wellness, beauty, and entrepreneurship—through elegance, evidence, and execution. 🌐 www.sundrata.com | www.azaverze.com
As Co-Founder and Chief Executive Officer of Sundrata Clinic, I lead the strategic vision, business leadership, and operational growth of a luxury rejuvenative medicine center in Summerlin, Las Vegas — dedicated to transforming lives through science-backed innovation, exceptional patient experience, and state-of-the-art personalized medicine. Sundrata delivers an elevated standard in aesthetic and metabolic wellness, offering bespoke programs that integrate personalized GLP-1 weight loss therapy, regenerative exosome treatments, non-invasive body contouring and muscle sculpting, skin rejuvenation, hair restoration, and sexual wellness solutions designed to restore confidence and vitality. Our technology portfolio includes Scarlet RF Microneedling, Nouvaderm Laser, Ultra+ for skin and hair health, and PlaDuo Pro — the only skin plasma device currently available in Las Vegas. My leadership spans the full spectrum of clinic development — from strategic planning and business development to clinical program design, operational oversight, team building, and patient experience innovation. I work closely with our multidisciplinary team to design science-backed protocols that are elegant in delivery, powerful in outcome, and timeless in artistry. 🌿 Services at Sundrata Clinic include: • Personalized GLP-1 Weight Loss Programs • Whole Body Transformation Protocols • Non-Invasive Skin Tightening & Muscle Sculpting • Skin Rejuvenation & Hair Restoration • Regenerative Exosome Therapies • Sexual Wellness & Intimate Health Solutions • 3D Body Composition & Progress Tracking • Lifestyle Optimization (Nutrition, Wellness Therapy, Fitness) Our mission is to scale Sundrata into a category-defining brand in luxury wellness and aesthetics, blending integrative longevity medicine with the aesthetics of confidence, radiance, and health.
I empower entrepreneurs and small business owners to achieve massive growth and success in today’s digital economy using AzAverze. AzAverze is a patent pending AI-driven business social media platform that integrates essential tools for networking, marketing, and e-commerce into a seamless solution. Entrepreneurs often face fragmented systems and inefficient workflows, making it challenging to scale their businesses effectively. AzAverze solves these problems by offering a platform that combines: • Business Networking: Build connections, collaborate, and discover growth opportunities. • Video Marketing: Engage audiences with impactful content to showcase products or services. • E-Commerce Tools: Manage online stores effortlessly to increase revenue. • AI Insights: Optimize decision-making and streamline operations with AI-powered tools. In addition to providing these cutting-edge features, my team and I offer business and leadership coaching, recognizing that technology alone isn’t enough. Entrepreneurs need guidance to navigate challenges, develop strategies, and lead with confidence. The AzAverze platform also includes The AzAverze Club, a mastermind network of highly trained business leaders with the theoretical and applied skills to mentor emerging business leaders to achieve greater success. At AzAverze, we combine innovative technology and human-centered coaching to empower business owners to thrive. My role as CEO involves setting the vision, driving innovation, and ensuring that our platform and services deliver real, measurable value to our customers. Our mission is to redefine entrepreneurial success by enabling small businesses to embrace technology, enhance their leadership, and unlock their full potential. Let’s connect to explore how AzAverze can help take your business to the next level!
Chief Medical Officer | Strategic Leader in Clinical Development & Biotech Innovation As Chief Medical Officer at Drug Farm, an innovative clinical-stage biotech company, I lead the strategic and clinical development of novel therapies driven by genetics 🧬 and artificial intelligence 🤖. My responsibilities encompass scientific leadership, operational strategy, and corporate growth, ensuring the advancement of transformative treatments for immune-related diseases 🏥. Key Achievements & Leadership ✅ Secured $27M in Series C financing 💰, presenting compelling clinical data, outlining corporate strategy, and addressing investor concerns. ✅ Leading Series D fundraising, forging strategic partnerships with U.S. 🇺🇸 and Chinese 🇨🇳 financial institutions to advance our innovative pipeline. Clinical & Regulatory Impact 🔬 Led Phase 1 strategic development and FDA approval of DF-003 and DF-006, pioneering immune modulators addressing significant unmet medical needs. 📈 Accelerated patient recruitment for DF-006’s Phase 1 study, achieving rapid enrollment and completing cohorts ahead of schedule. 🎤 Presented pivotal findings at the 2024 American and European Liver Conferences. Operational & Digital Transformation 🌍 Led multi-country regulatory engagements across the EU 🇪🇺 and APAC 🌏. 🚀 Spearheaded digital transformation of U.S. operations, building high-performing teams in safety, clinical operations, drug supply chain management, and regulatory affairs. 📊 Developed innovative data visualization platforms, optimizing medical monitoring and analysis. Corporate & Strategic Leadership 🤝 Collaborate closely with the CEO, driving corporate strategy, business development, investor relations, and organizational growth. 🌟 Passionate about advancing scientific innovation and operational excellence, dedicated to delivering life-changing therapies with a lasting global impact 🌎.
### **Senior Medical Director | Aligos Therapeutics & Janssen Pharmaceuticals** As a **Senior Medical Director** at **Aligos Therapeutics** and **Janssen Pharmaceuticals**, I led the design, execution, and oversight of clinical programs targeting infectious diseases, hepatology, and oncology. My role involved driving innovative therapies through early to late-stage development while ensuring alignment with regulatory standards and patient needs. I managed cross-functional teams to advance clinical strategies, collaborating with preclinical, regulatory, and commercial stakeholders to deliver on key milestones. Acting as the medical expert, I guided the creation of clinical trial protocols, target product profiles, and risk management strategies to ensure data integrity and compliance with GCP guidelines. My leadership extended to overseeing patient safety and regulatory submissions, where I facilitated successful engagements with health authorities such as the FDA and EMA. Key achievements include advancing first-in-class therapies in infectious diseases and liver conditions, securing FDA approval for investigational drugs, and achieving clinical trial enrollment milestones ahead of schedule. My ability to foster collaboration across teams and external stakeholders contributed to the efficient execution of global clinical trials. In addition to my strategic contributions, I published and presented findings at international conferences, enhancing the scientific understanding of virology and hepatology. My work at Aligos and Janssen reflects a deep commitment to innovation and delivering transformative therapies to patients worldwide. Through a blend of scientific expertise and operational leadership, I have consistently driven impactful outcomes in the biotech and pharmaceutical industries.
I this role I lead the hepatitis delta clinical development programs which involved a biologic compound, pegylated interferon lambda, and a small molecule compound lonafarnib. Eiger Biopharmaceuticals has since shutdown (https://www.biospace.com/eiger-files-for-bankruptcy-plans-to-shutter-operations-after-difficult-year)